首页|双歧杆菌三联活菌制剂对帕金森病患者代谢参数和肠道菌群的影响

双歧杆菌三联活菌制剂对帕金森病患者代谢参数和肠道菌群的影响

扫码查看
目的 探讨双歧杆菌三联活菌制剂治疗帕金森病(PD)的效果,为该类患者的治疗提供参考。方法 回顾性选取2023年1月至2023年10月我院收治的82例PD患者,按治疗方法划分组别。对照组患者共40例,给予多巴丝肼片治疗;试验组患者共42例,在对照组基础上给予双歧杆菌三联活菌制剂治疗。统计两组患者总有效率,比较两组治疗前后运动能力[帕金森病统一评分量表Ⅱ(UPDRS Ⅱ)]、日常生活活动能力[帕金森病统一评分量表Ⅲ(UPDRS Ⅲ)]、肠道菌群数量、代谢指标水平[总胆固醇(TC)、甘油三酯(TG)、胰岛β细胞功能指数(HOMA-β)、胰岛素抵抗指数(HOMA-IR)]。结果 试验组患者总有效率(76。19%)高于对照组(55。00%)(P<0。05)。在UPDRS Ⅱ、UPDRS Ⅲ评分方面,治疗后组间对比差异均有统计学意义(均P<0。05)。治疗12周后,试验组患者肠道双歧杆菌、乳杆菌数量高于对照组,酵母菌、肠球菌数量低于对照组(均P<0。05)。治疗12周后,两组患者TC、TG水平差异均无统计学意义(均P>0。05),而试验组HOMA-β、HOMA-IR均低于对照组(均P<0。05)。结论 双歧杆菌三联活菌制剂治疗PD效果显著,可调节患者肠道菌群,改善代谢指标水平,增强运动与日常生活活动能力。
Effects of Bifidobacterium Triplex on metabolic parameters and intestinal flora in patients with Parkinson's disease
Objective To observe the efficacy of Bifidobacterium Triplex in the treatment of Parkinson's disease(PD),providing a reference for the treatment.Methods A total of 82 patients with PD treated in our hospital from January 2023 to October 2023 were retrospectively selected and divided into groups according to different treatment methods.The con-trol group(40 cases)was given Levodopa and Benserazide Hydrochloride Tablets,the observation group(42 cases)was given Bifidobacterium Triplex on the basis of the treatment for control group.The total efficiency rates in the two groups were calculated.Athletic ability[unified PD rating scale Ⅱ(UPDRSⅡ)],activity of daily living[unified PD rating scale Ⅲ(UPDRS Ⅲ)],gut flora count,and metabolic parameters[total cholesterol(TC),triglyceride(TG),homeo-stasis model assessment isletβ-cell function index(HOMA-β)and homeostasis model assessment insulin resistance index(HOMA-IR)]were compared between groups before and after treatment.Results The total efficiency rate in obsevation group(76.19%)was higher than that in control group(55.00%)(P<0.05).In terms of UPDRS Ⅱ and UPDRS Ⅲ scores,there were significant differences in the post-treatment comparison between groups(all P<0.05).After 12 weeks of treatment,the counts of Bifidobacterium and Lactobacillus in observation group were higher,while those of yeast and Enterococcus were lower than those in control group,respectively(all P<0.05).After 12 weeks of treatment,there were no significant differences in TC and TG levels between the two groups(P>0.05),and the HOMA-β and HOMA-IR levels in the observa-tion group were lower than those in the control group(all P<0.05).Conclusion Bifidobacterium Triplex has significant effect in the treatment of PD,which can regulate intestinal flora,improve metabolic parameters,and enhance athletic abil-ity and activity of daily living.

Bifidobacterium TriplexParkinson's diseaseMetabolic parametersGut microbesAthletic abilityActivity of daily living

苏继超、何奕峰

展开 >

兰溪市人民医院神经内科,浙江 321100

双歧杆菌三联活菌制剂 帕金森病 代谢指标 肠道菌群 运动能力 日常生活活动能力

2024

中国微生态学杂志
中华预防医学会 大连医科大学

中国微生态学杂志

CSTPCD北大核心
影响因子:1.115
ISSN:1005-376X
年,卷(期):2024.36(6)